These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8556471)

  • 21. Solitary erythema migrans in Georgia and South Carolina.
    Felz MW; Chandler FW; Oliver JH; Rahn DW; Schriefer ME
    Arch Dermatol; 1999 Nov; 135(11):1317-26. PubMed ID: 10566829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune complexes in early Lyme disease.
    Lencáková D; Stefancíková A; Ivanová R; Petko B
    Can J Microbiol; 2007 Dec; 53(12):1375-7. PubMed ID: 18059570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
    Breier P; Klade H; Stanek G; Poitschek C; Kirnbauer R; Dorda W; Aberer E
    Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.
    Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J
    Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease.
    Berger BW; Johnson RC; Kodner C; Coleman L
    J Am Acad Dermatol; 1994 Jan; 30(1):48-51. PubMed ID: 8277030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reinfection with Borrelia burgdorferi in an immunocompetent patient].
    Hassler D; Maiwald M
    Dtsch Med Wochenschr; 1994 Mar; 119(10):338-42. PubMed ID: 8125037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lyme disease in clinical practice.
    Płusa T; Ligezińska B; Zabielski S; Raczka A
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():71-5. PubMed ID: 1292852
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of Erythema migrans Borreliosis in blood donors.
    Schmidt R; Gollmer E; Zunser R; Krüger J; Ackermann R
    Infusionstherapie; 1989 Dec; 16(6):248-51. PubMed ID: 2625363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
    Nadelman RB; Nowakowski J; Forseter G; Goldberg NS; Bittker S; Cooper D; Aguero-Rosenfeld M; Wormser GP
    Am J Med; 1996 May; 100(5):502-8. PubMed ID: 8644761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].
    Tschudi M
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1091-2. PubMed ID: 7939077
    [No Abstract]   [Full Text] [Related]  

  • 33. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans.
    Strle F; Nelson JA; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Cheng Y; Picken MM; Trenholme GM; Picken RN
    Clin Infect Dis; 1996 Jul; 23(1):61-5. PubMed ID: 8816130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.
    Engstrom SM; Shoop E; Johnson RC
    J Clin Microbiol; 1995 Feb; 33(2):419-27. PubMed ID: 7714202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
    Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
    J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rocky Mountain "spotless" fever with an erythema migrans-like skin lesion.
    Hughes C
    Clin Infect Dis; 1995 Nov; 21(5):1328-9. PubMed ID: 8589170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome.
    Kindstrand E
    Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
    Fung BP; McHugh GL; Leong JM; Steere AC
    Infect Immun; 1994 Aug; 62(8):3213-21. PubMed ID: 8039891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy.
    Schmidt B; Muellegger RR; Stockenhuber C; Soyer HP; Hoedl S; Luger A; Kerl H
    J Clin Microbiol; 1996 Jun; 34(6):1359-63. PubMed ID: 8735081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.